DBOL.NS Earnings Recap: Q2 2026 Results Released

Dhampur Bio Organics Limited released its DBOL.NS Q2 2026 earnings on (May, 20, 2026), delivering $4.86 billion in revenue and $2.55 earnings per share. The integrated sugarcane processing company, which operates across refined sugar, biofuels, and renewable power, reported results without prior guidance estimates. Following the announcement, DBOL.NS stock declined 0.76 points to $106.32, reflecting a -0.71% market reaction on the day.

DBOL.NS Earnings Preview: EPS and Revenue Expectations

Dhampur Bio Organics Limited reported Q2 2026 earnings with no consensus estimates available for comparison. The company generated $4.86 billion in quarterly revenue and posted $2.55 per share in earnings. With a market cap of $7.11 billion and 66.4 million shares outstanding, the results reflect the company’s scale in India’s agricultural processing sector.

The earnings announcement came as DBOL.NS stock traded near its 50-day average of $111.59. Year-to-date performance shows the stock up 35.29%, though it remains below its 52-week high of $130.73 set earlier in 2026.

Dhampur Bio Organics Limited Stock Valuation and Key Financial Metrics

DBOL.NS trades at a P/E ratio of 30.09, suggesting investors are pricing in future growth expectations. The price-to-sales ratio stands at 0.35, indicating relatively attractive valuation on revenue basis. Free cash flow per share reached $100.84, while operating cash flow per share totaled $103.77, demonstrating solid cash generation.

The company maintains a debt-to-equity ratio of 0.58, with interest coverage at 2.48 times. Return on equity sits at 2.4%, reflecting modest profitability relative to shareholder capital. Meyka AI rates DBOL.NS with a grade of B+, suggesting moderate investment appeal despite mixed fundamental signals.

What to Watch in Dhampur Bio Organics Limited Earnings Report

Gross profit margins expanded to 22.6% in trailing twelve months, up from prior periods, showing improved operational efficiency. Operating margins reached 8.14%, though net profit margins remain compressed at 1.17%. The company paid $1.25 per share in dividends, yielding 1.17% annually for shareholders.

Inventory turnover of 4.83 times and receivables turnover of 36.02 times indicate efficient working capital management. Days inventory outstanding stands at 75.6 days, typical for agricultural commodity processing businesses with seasonal demand patterns.

DBOL.NS Stock Forecast and Analyst Outlook

Technical indicators show mixed signals following the earnings release. The RSI at 37.04 suggests oversold conditions, while MACD remains negative at -1.23. The ADX reading of 25.15 confirms a strong downtrend is in place. Stochastic oscillators at 10.47 indicate extreme weakness in near-term momentum.

Monthly price forecasts suggest $106.24 as the near-term target, while quarterly models project $42.03. Volume declined to 49,878 shares versus the 293,046 average, signaling reduced trading interest post-earnings announcement.

Final Thoughts

Dhampur Bio Organics Limited’s Q2 2026 earnings delivered $4.86 billion in revenue and $2.55 EPS without prior estimates to benchmark performance. The stock’s -0.71% decline reflects cautious market sentiment despite solid cash generation and improved gross margins. With a B+ grade from Meyka AI and valuation metrics suggesting moderate appeal, investors should monitor working capital efficiency and margin trends in upcoming quarters.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.